Pulse Biosciences Inc. logo

Pulse Biosciences Inc.

PLSE | NASDAQ
Chart Builder DCF Calculator
$52.24
-$3.24 (-5.84%)
At close: Oct 30, 2026, 4:00 PM ET
$51.84
-$0.40 (-0.77%)
Pre-market: Nov 2, 2026, 9:10 AM ET

Market Data

Market Cap
$3.73B
Enterprise Value
$3.63B
Beta
1.57
Average Volume
475.13K
Shares Outstanding (Diluted)
69.2M
Shares Change YoY
2.86%
Institutional Ownership
15.70%
Exchange
NASDAQ
ISIN
US74587B1017

Price Performance

Price Change 1M
4.7%
Price Change 3M
48.7%
Price Change 6M
150.8%
Price Change YTD
280.5%
Price Change 1Y
208.6%
Price Change 3Y
1055.8%
Price Change 5Y
147.7%
1M CAGR (ann.)
-3.0%
1Y CAGR (ann.)
205.3%
5Y CAGR (ann.)
18.6%
All-Time CAGR
23.9%

Valuation

PE Ratio
-44.65
Forward PE
N/A
PEG Ratio
4.51
Forward PEG
-2.84
PS Ratio
3,144.21
Forward PS
660.40
PB Ratio
37.45
P/FCF Ratio
-60.69
P/Adj. FCF Ratio
-47.25
P/OCF Ratio
-59.36
EV/Sales
3,064.17
EV/EBIT
-45.04
EV/EBITDA
-45.47
EV/FCF
-59.15
Earnings Yield
-2.2%
FCF Yield
-1.6%
Adj. FCF Yield
-2.1%

Financial Health

Net Cash
$101.62M
Total Debt
$6.77M
Cash & Short-Term Investments
$101.62M
Total Assets
$115.56M
Current Ratio
9.63
Quick Ratio
9.61
Debt / Equity Ratio
0.07
Debt / EBITDA
-0.08
Debt / FCF
-0.11
OCF / Debt
-9.02
Interest Coverage
0.00
Altman Z-Score
131.72
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
-21.6%
Operating Profit Margin
-7007.8%
EBITDA Margin
-6717.4%
Net Profit Margin
-6755.8%
FCF Margin
-5180.4%
Adj. FCF Margin
-6654.9%
SBC / Revenue
1474.4%
SBC Impact (per share)
-28.5%

Returns

Return on Assets
-69.3%
Return on Equity
-94.4%
Return on Invested Capital
-78.1%
Return on Capital Employed
-79.4%
Return on Tangible Assets
-71.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
-28.4%
Revenue CAGR 10Y
23.4%
EPS CAGR 3Y
-18.8%
EPS CAGR 5Y
14.8%
EPS CAGR 10Y
6.3%
FCF CAGR 3Y
-27.4%
FCF CAGR 5Y
-5.0%
FCF CAGR 10Y
-11.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
2
EPS Growth Next 3Y
11.7%
Revenue Growth Next 3Y
270.2%
Earnings Date
Nov 5, 2026
EPS Estimate (next Q)
-$0.31
EPS Growth Est (next Q)
6.7%
Revenue Est (next Q)
$520.83K
Revenue Growth Est (next Q)
505.6%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$60.20
Price Target Upside
15.2%

Cash Flow

Operating Cash Flow
$-61.1M
Free Cash Flow
$-61.39M
Adj. Free Cash Flow
$-78.86M
FCF Per Share
-$0.89
OCF Per Share
-$0.88
OCF/S Ratio
-5155.9%

Income Statement

Revenue
$1.19M
Gross Profit
$-256K
Operating Income
$-83.04M
EBITDA
$-79.86M
Net Income
$-80.06M
EPS (Diluted)
-$1.17
Revenue / Employee
$10.22K
Profit / Employee
$-690.14K
Employees
116

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.